Expert Case Studies in Peripheral T-Cell Lymphoma
PROGRAM DESCRIPTION Peripheral T-cell lymphomas (PTCLs) are a group of rare and usually aggressive non-Hodgkin lymphomas (NHLs) that develop from mature T-cells and account for 10% of all NHL cases ...
Peripheral T-cell lymphomas (PTCLs) are a group of rare and usually aggressive non-Hodgkin lymphomas (NHLs) that develop from mature T-cells and account for 10% of all NHL cases in the United States.1 Despite advances in available treatment options, prognosis for PTCL remains poor compared to B-cell NHL, mostly due to poorer response rates and less durable responses to standard combination chemotherapy regimens.2 Individualized treatment and patient selection for the appropriate treatment approach in PTCL can be problematic especially for the community oncologist due to the rarity of PTCL. This unique case-based activity is designed to provide education to community oncologists that will highlight important issues in treating PTCL, which ultimately will improve patient outcomes.References1. Swerdlow SH, Campo E, Harris NL, et al, eds. World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France: IARC Press; 2008:262-268.2. Zelenetz AD, Gordon LI, Wierda WG, et al. Non-Hodgkin's lymphomas, version 4.2014. J Natl Compr Canc Netw. 2014;12(9):1282-1303.
Upon completion of this activity, participants should be able to:Discuss front-line therapy options for PTCL and the role of transplant in this settingDescribe special considerations in PTCL therapy options for elderly patients and those with comorbiditiesEvaluate the role of newer agents for relapsed/refractory PTCLDiscuss the common side effects of available PTCL treatment options and strategies to manage these side effects
I'm interested in this
Share with others
Write the first review
Share with others